Ticker: PGNY

Progyny

Healthcare Healthcare Medical - Healthcare Information Services
Price 36.16
Reco Buy Potential 68 Risk 40 Updated 2026-11-18

Forecast impact

limited
Target +5.1% target fill 95.2%
Reaction D5 +18.72% · D10 +17.28% fresh confirmed · market trust
Impact Potential 0 · Risk 0 valid until 2026-12-05

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Progyny is a healthcare company specializing in fertility benefits and services. Its core offerings include comprehensive fertility treatment coverage, personalized care, and access to a network of fertility specialists. The company primarily generates revenue through employer-sponsored fertility benefit plans, which cater to organizations seeking to support employees facing fertility challenges. Progyny's business segments focus on both direct-to-employer sales and partnerships with healthcare providers.

Investment Profile

The investment profile of Progyny is more aligned with growth investors, given its focus on expanding fertility services and increasing employer partnerships. The company demonstrates potential for revenue growth, supported by a favorable market environment. However, it does not currently offer dividends, making it less suitable for income-focused investors.

Fundamental metrics (experimental) Updated: 2026-11-14
EPS (TTM) — earnings per share for the last 12 months, $
1.15
Revenue QoQ — quarter-over-quarter revenue growth
-2.6%
EPS surprise
66.1%
20d volatility
3.4%
AI recommendation changes
Date Before After Reason
2026-10-21 Hold Buy Strong revenue growth and positive EPS surprise.
2026-10-17 Buy Hold Weak momentum and high risk; cautious approach advised.
2026-10-07 Hold Buy Positive EPS growth, but mixed momentum signals.
Analyst forecasts
Date Analyst Action Target Price Then
2026-11-05 Wells Fargo Target Raised — → 38 30.1
2026-11-05 Citizens Target Raised — → 38 34.37
2026-09-08 Jefferies Target Raised — → 33 25.94
News Page 1 of 1